broke downtrend and now creating its own little uptrend. now could be the time to get in.. hold as long as bottom trendline holds. conservative price target of 2 by mid may! still great returns :)
Bullish Flag Pros: Post forming with volume Descending volume during flag forming PPS above 50MA and 200MA RS above 0, and ascending ATR Ascending R/R ratio above 5 Cons: 250RSI below 50 200MA flat 50MA below 200MA Target: PT = 1.7552$ 1000 Followers! Thank you all! Thank you to those who donate Coins! Stay Humble, have fun, make money!
Market is really messy this week, but wanted to get a handle on where ASRT is headed. There was a wedge someone else posted a while back that it broke out of, but it is in a larger one now. After today's drop it bounced off the bottom edge, hoping for a golden cross soon and breakout back to $1 area.
Previous analysis on this ticker: Search for "ASRT Current Setup" Today was pretty good, since last analysis it had bounced twice on the bottom of the wedge, and now with the market heating back up we had some pops at the end of the day which got it in a much more comfortable zone I think. We still need to break up out of this wedge, but that seems a lot more...
ASRT falling hard same as the whole stock market. But can open some good opportunities! Volume is coming in last weeks good sign there is something awakening! I watch the trend line closely this weeks if it hit I wil buy a big bag of ASRT! That good indicate a retest whats significant! Keep an aye on ASRT!
I have seen that ASRT needs to stay above 1.00 for 10 days in order to stay compliant with Nasdaq listing. According to the chart, that means the compliance will be completed on Monday Feb 22 if they close above 1.00. Now multiple scenarios could happen once compliance is reached. Buying pressure could lower which could make the price tank below 1.00, as they do...
ASRT, nice bull flag, volume is running out indicates accumulation is coming to an end soon! And we have broken a big trend line a view days ago! It is good possible we will see an nice move to the upside! Also RSI indicates nice downward channel that's also an bullish consolidation.
ASRT formed a Symmetrical triangle The support of the lower boundary of the triangle was broken, so the target became 0.65 Stop losing if it closes above the upper bound of the triangle
"Assertio is a pharmaceutical company that sells prescription products in 3 areas: neurology, hospital, and pain and inflammation. The company is currently undergoing major restructuring and has recently merged with Zyla Life Sciences. They have 7 FDA approved products in the marketplace. Assertio currently has a market cap of only $150 million and has raised $50...
After the successful run of OPTT, we are in another penny stock ASRT
Template Possible move:73% Reward/Risk: 5(R/R>3 is Ideal) Time frame: 1-4wks This is just my technical view, not a fundamental comment..! I can make you confused by a crowded messy chart, but I would rather simple effective presentations..! Watchlist: Look for breaking upward
Still need confirmation - Assertio Holdings, Inc. operates as a holding company. The firm develops pharmaceuticals. It engages in the provision of solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.
WHATCH FOR NECKLINE BREAK AND BUY TH EDIP B4 THE BREAK...IT WILL BOUNCE OFF THE RESISTANCE FIRST
Contextual immersion trading strategy idea. Assertio Therapeutics, Inc., a specialty pharmaceutical company, provides medicines in neurology, orphan, and specialty areas in the United States. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long...
Collegium Pharmaceutical (NASDAQ:COLL) +8.3% after-hours on news it agrees to acquire the U.S. rights to the Nucynta franchise from Assertio Therapeutics (NASDAQ:ASRT) for $375M; ASRT +56.7%. Collegium calls the deal "financially transformative... We expect the acquisition to improve annual EBITDA and operating cash flows by more than $100M." The company says...